No Data
No Data
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
TELA Bio First Quarter 2024 Earnings: US$0.23 Loss per Share (Vs US$0.63 Loss in 1Q 2023)
TELA Bio | 10-Q: Quarterly report
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,
TELA Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Revenue Results and Raised Its FY24 Revenue Guidance.
TELA Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Revenue Results and Raised Its FY24 Revenue Guidance.
TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler
TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler
No Data